Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06234085
Other study ID # STUDY00015707
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2022
Est. completion date June 30, 2023

Study information

Verified date January 2024
Source University of Washington
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this randomized, single-blinded, educational study is to test the effect of providing crowdsourced ratings and feedback to second-year (PGY2) internal medicine (IM) and family medicine (FM) resident physicians' about their adverse event communication skills. The main question it aims to answer is: - Is the intervention of providing reports with personal performance feedback and recommendations for effective error disclosure associated with higher ratings of resident error disclosure skills? Participants will perform simulated error disclosure with a software tool called the Video-based Communication Assessment (VCA). Participants will be randomized to receive feedback reports (intervention) or not (control). Participants receiving the intervention will be asked to review their feedback and all participants will use the VCA again approximately 4 weeks later with different patient cases.


Description:

Participating residency programs assigned all eligible post-graduate year 2 (PGY2s) to attend a 75-minute teaching session at Time 1, consisting of 50 minutes of lecture about communication with patients after medical harm, 20 minutes of VCA practice with two cases (containing 4 and 3 sequenced vignettes, respectively), and 5 minutes of debrief. At Time 2, residents attended a session consisting of 25 minutes of lecture about institutional programs to support clinicians with error disclosure and 20 minutes of VCA practice with two additional cases (3 sequenced vignettes each). The recommended duration between Time 1 and Time 2 was four weeks, although the conference schedule at two residencies required an interval of 5 to 8 weeks for some residents. Residents who completed the VCA at Time 1 were randomized in 1:1 fashion to either receive feedback before Time 2 (intervention) or after Time 2 (control). Intervention residents received emails when their feedback was available, instructing them to review it in the app before the next teaching session and VCA practice. Feedback was typically provided two weeks after VCA use to allow for completion of rating and data quality checks. Reports presented an interactive feedback display within the VCA app for each vignette. Residents provided audio responses to each vignette through the VCA software. Audio responses were bundled into rating tasks on MTurk for raters who were US residents over 18 years old and able to speak and read English. Raters answered demographic questions, read a vignette description in lay language, viewed the patient video, and listened to resident responses. They rated each response on six items covering domains of error disclosure. We averaged ratings across items and raters to create an overall rating of each response. We then averaged response ratings across all 7 vignettes at Time 1 to create an overall Time 1 score, and across all 6 vignettes at Time 2 to create a Time 2 score. Residents completed questionnaires in the VCA application before proceeding to cases. The survey at Time 1 asked about age, gender, race, the number of times the resident had personally participated in disclosure of a harmful error to a patient or family, and the highest level of involvement they've had during disclosure of a harmful medical error. Before Time 2, residents who had received feedback were asked "approximately how many minutes did you spend reviewing your feedback" (response options in 5-min ranges), and "how many of your own responses did you replay", "how many of the exemplar (highly rated peer) responses did you play", (response options of none, 1-2, 3-4, 5 or more). Residents responded to four additional items (Table 2) about the usefulness of each feedback component (scores, personal recordings, exemplar recordings, learning points) using a 5-point scale with labels from "not at all" to "extremely" To address our primary study question about the effect of the intervention, i.e., access to VCA feedback, we conducted a factorial analysis of covariance (ANCOVA) examining the impact that the intervention and prior disclosure exposure had on Time 2 scores, while adjusting for Time 1 scores. We used logistic regression to investigate whether Time 1 scores could predict the likelihood participants returned for Time 2.


Recruitment information / eligibility

Status Completed
Enrollment 154
Est. completion date June 30, 2023
Est. primary completion date May 15, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Enrolled in the second post-graduate year (PGY2) of an Internal Medicine or Family Medicine Residency Exclusion Criteria: - Declines research use of audio recordings

Study Design


Related Conditions & MeSH terms


Intervention

Other:
VCA feedback report available
Access to feedback report described in the intervention

Locations

Country Name City State
United States University of Washington at Boise Boise Idaho
United States Beaumont Health Dearborn Michigan
United States Washington State University at Everett Everett Washington
United States Dartmouth Hitchcock Medica Center Lebanon New Hampshire
United States Washington University in St. Louis Saint Louis Missouri
United States University of Washington Seattle Washington
United States University of Massachussets Worcester Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
University of Washington The National Board of Medical Examiners

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Summary crowdsourced rating A numerical score representing an average of scores of a participant's communication skills provided by panels of crowdsourced laypeople who listened to audio recordings of participants responding to a VCA case. The second of two time points for VCA use (4 weeks after first use)
Secondary Survey about prior disclosure experience Survey with items asking about prior experience with error disclosure, provided to all participants. Before the first VCA use
Secondary Survey about VCA feedback use in intervention arm Survey asking about self-reported use of feedback components, provided to the intervention arm participants only. Before the second VCA use (4 weeks after first use)
See also
  Status Clinical Trial Phase
Completed NCT06366607 - Managing High-alert Medication Administration and Errors
Completed NCT04659265 - A Priori Diagnosis and Diagnostic Errors N/A